Kit and method for detecting cryptosporidium
Through specific primer pairs and crRNA combined with RPA amplification and CRISPR detection technology, the problem of insufficient sensitivity and long time in the Cryptosporidium detection method is solved, and high sensitivity, high specificity and rapid detection are achieved, reducing equipment requirements.
Patent Information
- Application Number
- CN202411447500.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-16
- Publication Date
- 2024-12-06
AI Technical Summary
The existing Cryptosporidium detection methods have problems such as insufficient sensitivity, poor specificity, complex operation and long time. In particular, the Crown PCR method takes 4-5 hours and has high equipment requirements.
Using specific primer pairs and crRNA-bound RPA amplification and CRISPR detection technology, fluorescence signals were detected using Cas12a enzyme and ssDNA fluorescence reporter probes to simplify operation and shorten reaction time.
High sensitivity and specificity detection of Cryptosporidium is achieved, and the reaction time is shortened to 1 hour, reducing the requirements for detection equipment and improving detection efficiency.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present application relates to the field of biotechnology, and in particular to a kit and method for detecting Cryptosporidium. Background Art
[0002] Cryptosporidium is an important zoonotic intestinal protozoan with a wide host range. It can infect a variety of vertebrates including mammals, birds, reptiles, amphibians and fish, including humans. It mainly parasitizes in the host's gastrointestinal epithelial cells. Currently, 31 species are considered effective, and the more common zoonotic species are Cryptosporidium parvum (C. parvum) and Cryptosporidium hominis (C. hominis). Cryptosporidium is mostly transmitted through contaminated water and food. Infection with it can cause zoonotic parasitic diseases with diarrhea as the main clinical symptom, posing a serious threat to the health of humans and animals.
[0003] Traditional detection methods for Cryptosporidium include fecal smear microscopy, immunological methods, and nucleic acid detection methods. Fecal smear microscopy is time-consuming and labor-intensive, has low specificity, and has large errors. Immunological techniques also have disadvantages such as insufficient sensitivity and complex operation. Among the nucleic acid detection methods for Cryptosporidium, most use nested-PCR after two rounds of amplification and then run on gels. The operation process is relatively cumbersome, takes about 4-5 hours, and is prone to contamination. Summary of the invention
[0004] Based on this, it is necessary to provide a primer pair and crRNA reaction reagent for detecting Cryptosporidium with high sensitivity and good specificity in one embodiment of the present application; based on this, a method for detecting Cryptosporidium is also provided, which has sensitive and good specificity, simple operation and short reaction time.
[0005] The technical solutions include the following:
[0006] A primer pair for detecting Cryptosporidium, the primer pair comprising primers with sequences as shown in SEQ ID NOs: 3-4.
[0007] The crRNA used to detect Cryptosporidium includes a crRNA with a sequence as shown in SEQ ID NO: 5.
[0008] A reaction reagent for detecting Cryptosporidium, the reaction reagent comprising an RPA amplification reaction reagent and a CRISPR detection reaction reagent; the RPA amplification reaction reagent comprises the primer pair, and the CRISPR detection reaction reagent comprises the crRNA.
[0009] In one embodiment, the RPA amplification reaction reagents also include one or more of RPA reaction microspheres and a dissolving agent for dissolving the microspheres.
[0010] In one embodiment, the CRISPR detection reaction reagent also includes one or more of a Cas12a enzyme, a CRISPR reaction buffer, and a ssDNA fluorescent reporter probe.
[0011] A kit for detecting Cryptosporidium includes the primer pair, the crRNA or the reaction reagent.
[0012] Use of the primer pair, the crRNA or the reaction reagent in preparing a kit for detecting Cryptosporidium.
[0013] The method for detecting Cryptosporidium includes the following steps:
[0014] Using DNA as a template, performing RPA isothermal amplification using the primer pair;
[0015] Using the obtained RPA amplification product as a template, adding the defined CRISPR detection reaction reagent to perform CRISPR reaction, and detecting the fluorescent signal; and
[0016] Determine whether the sample to be tested contains Cryptosporidium based on the test results.
[0017] In one embodiment, RPA isothermal amplification satisfies one or more of the following conditions:
[0018] (1) In the RPA isothermal amplification reaction system, the concentration of each primer is 0.3 μM to 1 μM; and,
[0019] (2) The reaction conditions of RPA isothermal amplification include a temperature of 40°C to 45°C and a time of 15 min to 30 min.
[0020] In one embodiment, the CRISPR reaction satisfies one or more of the following conditions:
[0021] (1) In the CRISPR reaction system, the concentrations of crRNA, Cas12a enzyme protein and ssDNA fluorescent reporter probe are 5nM~10nM, 0.2μM~1μM and 0.2μM~1μM respectively; and,
[0022] (2) CRISPR reaction conditions include temperature of 36°C~38°C and reaction time of 22min~30min.
[0023] Compared with the traditional technology, this application has the following beneficial effects:
[0024] The detection of Cryptosporidium using the primers and crRNA of the present application has the advantages of high sensitivity and good specificity; the detection method of Cryptosporidium based on the primers and crRNA also has high sensitivity and high specificity, and short reaction time. The test results of a single nucleic acid sample can be obtained within 1 hour, which can be shortened by 5 hours compared with the national standard nested PCR method; in addition, compared with the real-time fluorescence PCR method, the reaction process can be completed in a constant temperature range of 40-45 degrees, and the requirements for detection equipment are relatively low. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the technical solutions in the embodiments of the present application and to more completely understand the present application and its beneficial effects, the following is a brief introduction to the drawings required for the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present application, and those skilled in the art can obtain other drawings based on these drawings without creative work.
[0026] Figure 1 The electrophoresis results of the two pairs of RPA primers in Example 1 after detecting the samples;
[0027] Figure 2 The CRISPR detection results of Cry RNA1 and Cry RNA2 in Example 1;
[0028] Figure 3 This is the result of the serial dilution CRISPR test of Cryptosporidium plasmid samples;
[0029] Figure 4 The results of the plasmid samples for Enterosporidiosis, Cryptosporidium, Entamoeba histolytica, Cyclospora, and Giardia lamblia;
[0030] Figure 5 The test results of RPA-CRISPR in this application for known negative and positive samples for the national standard test for Cryptosporidium;
[0031] Figure 6 This is the test result of the sample of Comparative Example 1. DETAILED DESCRIPTION
[0032] In order to make the above-mentioned purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are described in detail below. In the following description, many specific details are set forth to facilitate a full understanding of the present application. However, the present application can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present application, so the present application is not limited by the specific embodiments disclosed below.
[0033] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those skilled in the art to which the present application belongs. The terms used herein in the specification of the present application are only for the purpose of describing specific embodiments and are not intended to limit the present application. The term "and / or" used herein includes any and all combinations of one or more of the related listed items.
[0034] In this application, unless otherwise specified, "one or more" means any one of the listed items or any combination of the listed items. Similarly, "one or more" and the like, when used in other ways to mean "one or more", are also understood in the same way unless otherwise specified.
[0035] In this application, "optionally", "optional", and "optional" mean optional, that is, any one of the two parallel solutions of "yes" or "no". If there are multiple "optional" in a technical solution, unless otherwise specified and there is no contradiction or mutual restriction, each "optional" is independent. Unless otherwise specified, the descriptions of "optionally include", "optionally contain", etc. in this application, taking "optionally include" as an example, mean "may include or not include".
[0036] The terms "contain", "include" and "include" used in this application are synonymous, which are inclusive or open-ended and do not exclude additional, uncited members or features. Members or features include materials or components, structures, elements, instruments, etc.; non-limiting examples of members or features include actions, conditions for the occurrence of actions, timing, states, etc.
[0037] In this application, the technical features or technical solutions described in an open language include closed technical features or technical solutions composed of the listed contents, and also include open technical features or technical solutions containing the listed contents.
[0038] In the present application, exemplary descriptions such as "in one embodiment", "in a specific example," etc. may include but are not limited to the following meanings: these solutions can be combined with other solutions in a suitable manner to form a new technical solution.
[0039] In the present application, in "the first aspect", "the second aspect", "the third aspect", "the fourth aspect", etc., the terms "first", "second", "third", "fourth", etc. are used only for descriptive purposes and cannot be understood as indicating or implying relative importance or quantity, nor can they be understood as implicitly indicating the importance or quantity of the indicated technical features. Moreover, "first", "second", "third", "fourth", etc. only serve the purpose of non-exhaustive enumeration and description, and it should be understood that they do not constitute a closed limitation on quantity.
[0040] In the present application, when it comes to a numerical interval (i.e., a numerical range), unless otherwise specified, the distribution of the optional numerical values in the numerical interval is considered to be continuous, and includes the two numerical endpoints (i.e., the minimum and maximum values) of the numerical interval, and each numerical value between the two numerical endpoints. Unless otherwise specified, when the numerical interval only refers to an integer in the numerical interval, it includes the two endpoint integers of the numerical range, and each integer between the two endpoints, which is equivalent to directly listing each integer. When multiple numerical ranges are provided to describe features or characteristics, these numerical ranges can be merged. In other words, unless otherwise specified, the numerical range disclosed herein should be understood to include any and all sub-ranges included therein. The "numerical value" in the numerical interval can be any quantitative value, such as a number, a percentage, a ratio, etc. "Numerical interval" allows broadly including numerical interval types such as percentage intervals, ratio intervals, and ratio intervals.
[0041] In this application, if there are multiple steps involved in the method flow, unless there is a clear different description in this document, there is no strict order restriction for the execution of these steps, and they can be executed in other orders than described. Moreover, any step can include multiple sub-steps or multiple stages, and these sub-steps or stages are not necessarily executed at the same time, but can be executed at different times, and their execution order is not necessarily sequential, but can be executed in turn, alternating or simultaneously with other steps or parts of sub-steps or stages of other steps.
[0042] The explanations of the English abbreviations involved in this application are as follows:
[0043] RPA, Recombinase polymerase amplification;
[0044] CRISPR, clustered regularly interspaced short palindromic repeats, regularly clustered interspaced short palindromic repeats nucleic acid sequence.
[0045] In view of the long detection time and high equipment requirements of the current nested PCR technology, isothermal amplification technology is used for Cryptosporidium detection. This technology does not require a temperature change control device such as a PCR instrument, and has low requirements for instruments and equipment. Isothermal amplification can be completed within 20 minutes. In order to solve the false positive problem that may occur in the isothermal amplification detection process, the CRISPR detection technology is combined to design the crRNA sequence for the target area. After the crRNA binds to the target sequence, it forms a trimer with the Cas12a protein to stimulate its reverse cutting activity, which can complete the cutting of the single-stranded DNA in the reaction system, thereby stimulating the fluorescence signal of the ssDNA reporter. The detection results of isothermal amplification combined with CRISPR technology are more accurate.
[0046] One embodiment of the present application provides a primer pair for detecting Cryptosporidium, the primer pair comprising a primer pair as shown in SEQ ID NO: 3 and SEQ ID NO: 4. Among them, SEQ ID NO: 3 is an upstream primer, and SEQ ID NO: 4 is a downstream primer.
[0047] One embodiment of the present application also provides a crRNA for detecting Cryptosporidium, which crRNA includes the crRNA shown in SEQ ID NO: 5.
[0048] One embodiment of the present application also provides a reaction reagent for detecting Cryptosporidium, which comprises an RPA amplification reaction reagent and a CRISPR detection reaction reagent.
[0049] In a specific example, the RPA amplification reaction reagents include the above-mentioned primer pair.
[0050] In a specific example, the CRISPR detection reaction reagent includes the above-mentioned crRNA.
[0051] The above reaction reagent is used to detect Cryptosporidium with high specificity and high sensitivity.
[0052] In a specific example, the RPA amplification reaction reagents also include RPA reaction microspheres and a dissolving agent for dissolving the microspheres.
[0053] In a specific example, the CRISPR detection reaction reagents also include Cas12a enzyme, CRISPR reaction buffer and ssDNA fluorescent reporter probe.
[0054] When CRISPR-Cas12 family nucleases target double-stranded DNA under the guidance of guide RNA, single-stranded DNase activity is activated, and they can non-specifically and indiscriminately cut nearby single-stranded DNA molecules.
[0055] One embodiment of the present application also provides a kit for detecting Cryptosporidium, comprising the above-mentioned primer pair, the above-mentioned crRNA or the above-mentioned reaction reagent.
[0056] One embodiment of the present application also provides the use of the above-mentioned primer pair, the above-mentioned crRNA or the above-mentioned reaction reagent in preparing a kit for detecting Cryptosporidium.
[0057] One embodiment of the present application also provides a method for detecting Cryptosporidium, which is simple to operate, has a short reaction time, can produce a test result within 1 hour, has low requirements for detection equipment, can realize rapid on-site detection, and has high detection sensitivity and good specificity. Specifically, it includes the following steps S1 to S3:
[0058] Step S1, using DNA as a template, and using the primer pairs shown in SEQ ID NOs: 3-4 to perform RPA isothermal amplification.
[0059] In this application, the nucleic acid of the sample to be tested is used as a template, and the RPA primers of Cryptosporidium are used to perform RPA isothermal amplification to obtain RPA products; the detection results of the RPA products are judged by specific bands of gel electrophoresis to explore measures such as reagent ratio, temperature and time control.
[0060] In a specific example, in the reaction system of RPA isothermal amplification, the concentration of each primer is 0.3 μM to 1 μM. In a specific example, the concentration of each primer is 0.3 μM, 0.4 μM, 0.5 μM, 0.6 μM, 0.7 μM, 0.8 μM, 0.9 μM, 1 μM, or a range between any two of the above values.
[0061] In a specific example, the reaction conditions of RPA isothermal amplification include a temperature of 40°C to 45°C and a time of 15min to 30min. In a specific example, the temperature of the RPA isothermal amplification reaction is 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, or a range between any two of the above values. In a specific example, the time of the RPA isothermal amplification reaction is 15min, 16min, 17min, 18min, 19min, 20min, 22min, 25min, 28min, 30min, or a range between any two of the above values.
[0062] Step S2, using the obtained RPA amplification product as a template, adding the above-mentioned CRISPR detection reaction reagent to carry out CRISPR reaction, and detecting the fluorescence signal.
[0063] In a specific example, in the CRISPR reaction system, the concentration of crRNA is 5nM to 10nM. In a specific example, the concentration of crRNA is 5nM, 6nM, 6.25nM, 7nM, 8nM, 9nM, 10nM, or a range between any two of the above values.
[0064] In a specific example, in the CRISPR reaction system, the concentration of Cas12a enzyme protein is 0.2 μM-1 μM. In a specific example, the concentration of Cas12a enzyme protein is 0.2 μM, 0.3 μM, 0.4 μM, 0.5 μM, 0.6 μM, 0.7 μM, 0.8 μM, 0.9 μM, 1 μM, or a range between any two of the above values.
[0065] In a specific example, in the CRISPR reaction system, the concentration of the ssDNA fluorescent reporter probe is 0.2 μM-1 μM. In a specific example, the concentration of the ssDNA fluorescent reporter probe is 0.2 μM, 0.3 μM, 0.4 μM, 0.5 μM, 0.6 μM, 0.7 μM, 0.8 μM, 0.9 μM, 1 μM, or a range between any two of the above values.
[0066] In a specific example, the CRISPR reaction conditions include a temperature of 36°C to 38°C and a time of 22min to 30min. In a specific example, the temperature of the CRISPR reaction is 36°C, 36.5°C, 37°C, 37.5°C, 38°C, or a range between any two of the above values. In a specific example, the time of the CRISPR reaction is 22min, 23min, 24min, 25min, 26min, 27min, 28min, 29min, 30min, or a range between any two of the above values.
[0067] In one specific example, the CRISPR reaction conditions include 37° C. for 30 min.
[0068] Step S3, judging whether the sample to be tested contains Cryptosporidium according to the detection result.
[0069] In a specific example, the detection sample includes but is not limited to one or more of water and food. It is understandable that in other examples, the detection sample can also be a sample in other environments.
[0070] The embodiments of the present application will be described in detail below in conjunction with examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods for which specific conditions are not specified in the following examples are preferably referred to the guidance provided in the present application, and can also be based on the experimental manual or normal conditions in this area, can also be based on the conditions recommended by the manufacturer, or refer to experimental methods known in the art.
[0071] In the following specific embodiments, the measured parameters of raw material components may have slight deviations within the range of weighing accuracy unless otherwise specified. For temperature and time parameters, acceptable deviations caused by instrument test accuracy or operation accuracy are allowed.
[0072] The main reagents involved in the following examples are as follows: RPA reagent (Suzhou Xianda), Cas12a enzyme (Toluo Bio), ssDNA Reporter reporter (Toluo Bio), CRISPR reaction buffer (Toluo Bio), sterile deionized water, Enterocytozoon bieneusi (GenBank ID: OQ646733.1), Cryptosporidium (GenBank ID: CP040059.1), Entamoeba histolytica (GenBank ID: PP275727.1), Cyclospora papionis (GenBank ID: AF111187.1) and Giardia intestinalis (GenBank ID: MN629930.1) plasmids constructed respectively.
[0073] Example 1
[0074] 1. RPA Primer Pair Screening
[0075] (1) Design RPA primer pairs for Cryptosporidium. The main screening indicators for the design of RPA primers are as follows:
[0076] a) Primer length: 28-35bp; b) Primer Tm value: 50-75; c) Primer GC content: 30%-70%; d) Primer sequence should avoid repeating sequences (forward / reverse) of more than 5 bases, hairpin structures, or palindromic structures of more than 8 bases; e) Dimers should be avoided as much as possible between upstream and downstream primers themselves and between primers; especially the first 5 bases at the 3' end; g) Guanine (G) should be avoided in the 3-5bp at the 5' end of the primer; h) The presence of guanine (G) and cytosine (C) in the last 3bp at the 3' end of the primer is conducive to the reaction, which may be conducive to the binding of the polymerase; i) The length of the amplified product should preferably be 100-200bp.
[0077] The RPA primer pairs are shown in Table 1.
[0078] Table 1
[0079]
[0080] (2) Detection of Cryptosporidium plasmid samples using RPA reaction (20 copies / μl, 2 copies / μl):
[0081] Each reaction contained: RPA reaction microspheres, 2.5 μl of upstream and downstream primers (10 μM), 5 μl of sample to be tested, 20 μl of solvent for dissolving RPA microspheres, 17 μl of sterile RNase-free deionized water, and 3 μl of activation solution.
[0082] The upstream and downstream primer pairs are respectively the primer pairs of cryRAAF2 and cryRAAR2, or the primer pairs of cryRAAF4 and cryRAAR34.
[0083] Incubate at 45 degrees for 20 minutes to obtain RPA product, and the detection result of RPA product is judged by specific bands of gel electrophoresis.
[0084] Test results are shown in Figure 1 Among them, A01 is 20 copies / μl, A02 is 2 copies / μl, and the plasmid samples are tested using the primer pair of cryRAAF4 and cryRAAR34; A03 is 20 copies / μl, A04 is 2 copies / μl, and the plasmid samples are tested using the primer pair of cryRAAF2 and cryRAAR2.
[0085] It can be seen that the bands detected by the cryRAAF4 and cryRAAR34 primer pairs are clearer and more specific.
[0086] 2. crRNA sequence screening
[0087] 2.1 The design method of crRNA is as follows: select a 20 bp Target sequence in the region to be tested. The region should be relatively conservative and must be connected to TTN in front. According to the base sequence of the Target region, T is converted to U to become the target sequence form of crRNA, and the common anchor sequence that binds to the Cas12a protein is connected in front.
[0088] The crRNA sequence is designed as shown in Table 2, and the crRNA sequence includes an anchor sequence for binding to the Cas12a protein and a guide sequence targeting the Cryptosporidium target sequence.
[0089] Table 2
[0090]
[0091] 2.2 RPA was used to detect the Cryptosporidium plasmid sample (1 copy / μl) and the negative control ddH2O, and then CRISPR detection was performed using two crRNAs, cry RNA1 and cry RNA2, to verify the reaction effect.
[0092] 2.2.1 RPA response
[0093] Each reaction contained: RPA reaction beads, 2.5 μl of upstream and downstream primers cryRAAF4 (10 μM) and cryRAAR34 (10 μM), 5 μl of the sample to be tested, 20 μl of the dissolving agent, 17 μl of sterile RNase-free deionized water, and 3 μl of activation solution.
[0094] Incubate at 45 degrees for 20 minutes to obtain the RPA product.
[0095] 2.2.2 CRISPR reaction
[0096] Each reaction system is 20 μl: 2 μl CRISPR reaction buffer, 1 μl ssDNA Reporter (10 μM), 0.5 μl crRNA (250 nM), 13.5 μl water, 2 μl RPA product to be tested, 1 μl Cas12a enzyme (10 μM). The crRNAs are cry RNA1 and cry RNA2.
[0097] The fluorescence PCR instrument detects the fluorescence signal, the reporter signal is FAM, the quenching group is none, the control group is none, the fluorescence signal is tested every 20 seconds at 37 degrees, for a total of 90 cycles, and the analysis window selects mulitcomponent data.
[0098] Result determination: within the same detection time, if the fluorescence intensity value of the experimental group is more than 3 times higher than that of the negative control (ddH2O), and there is a detailed amplification curve, it is determined to be a positive result, that is, the sample to be tested contains or is a candidate for containing Cryptosporidium nucleic acid; otherwise, it is a negative result, that is, the sample to be tested does not contain Cryptosporidium nucleic acid.
[0099] Test results are shown in Figure 2 , it can be seen that the cry RNA2 negative control result showed a typical amplification curve, which was a false positive result.
[0100] Example 2
[0101] First, 4 μg of the Cryptosporidium plasmid sample to be tested was dissolved in 400 μl of water, and then diluted in multiples to a final dilution of 200 copies / μl, 20 copies / μl, 1 copies / μl and 0.5 copies / μl for testing to determine the sensitivity of the reaction.
[0102] 1. RPA reaction
[0103] Each reaction contained: RPA reaction beads, 2.5 μl of upstream and downstream primers cryRAAF4 (10 μM) and cryRAAR34 (10 μM), 5 μl of the sample to be tested, 20 μl of the dissolving agent, 17 μl of sterile RNase-free deionized water, and 3 μl of activation solution.
[0104] Incubate at 45 degrees for 20 minutes to obtain RPA products, and the amplification results of RPA products are judged by specific bands of gel electrophoresis.
[0105] 2. CRISPR reaction
[0106] Each reaction system is 20 μl: 2 μl CRISPR reaction buffer, 1 μl ssDNA Reporter (10 μM), 0.5 μl Cry RNA1 (250 nM), 13.5 μl water, 2 μl RPA product to be tested, and 1 μl Cas12a enzyme (10 μM).
[0107] Use a fluorescent PCR instrument to detect fluorescent signals, with FAM as the reporter signal, none as the quencher group, and none as the control group. Test the fluorescent signal every 20 seconds at 37 degrees for 90 cycles in total, and select multicomponent data in the analysis window.
[0108] Result determination: within the same detection time, if the fluorescence intensity value of the experimental group is more than 3 times higher than that of the negative control (ddH2O), and there is a detailed amplification curve, it is determined to be a positive result, that is, the sample to be tested contains or is a candidate for containing Cryptosporidium nucleic acid; otherwise, it is a negative result, that is, the sample to be tested does not contain Cryptosporidium nucleic acid.
[0109] The results of the CRISPR test of the Cryptosporidium plasmid sample were as follows: Figure 3 As shown in Table 3, part of the detection data shows that the fluorescence signal values of the positive plasmids at concentrations above 1 copies / μl are more than 3 times greater than the fluorescence values of the negative control.
[0110] Table 3 Fluorescence signal values of diluted positive plasmid and negative control at different detection time points
[0111]
[0112] Example 3
[0113] The plasmids constructed for Enterocytozoon bieneusi (GenBank ID: OQ646733.1), Cryptosporidium (GenBank ID: CP040059.1), Entamoeba histolytica (GenBank ID: PP275727.1), Cyclospora papionis (GenBank ID: AF111187.1) and Giardia intestinalis (GenBank ID: MN629930.1) were taken at 20 copie / μl for detection to determine the specificity of the method.
[0114] 1. RPA reaction
[0115] Each reaction contained: RPA reaction beads, 2.5 μl of upstream and downstream primers cryRAAF4 (10 μM) and cryRAAR34 (10 μM), 5 μl of the sample to be tested, 20 μl of the dissolving agent, 17 μl of sterile RNase-free deionized water, and 3 μl of activation solution.
[0116] Incubate at 45 degrees for 20 minutes to obtain RPA products, and the amplification results of RPA products are judged by specific bands of gel electrophoresis.
[0117] 2. CRISPR reaction
[0118] Each reaction system is 20 μl: 2 μl CRISPR reaction buffer, 1 μl ssDNA Reporter (10 μM), 0.5 μl Cry RNA1 (250 nM), 13.5 μl water, 2 μl RPA product to be tested, and 1 μl Cas12a enzyme (10 μM).
[0119] Use a fluorescent PCR instrument to detect fluorescent signals, with FAM as the reporter signal, none as the quencher group, and none as the control group. Test the fluorescent signal every 20 seconds at 37 degrees for 90 cycles in total, and select mulitcomponent data in the analysis window.
[0120] Result determination: within the same detection time, if the fluorescence intensity value of the experimental group is more than 3 times higher than that of the negative control (ddH2O), and there is a detailed amplification curve, it is determined to be a positive result, that is, the sample to be tested contains or is a candidate for containing Cryptosporidium nucleic acid; otherwise, it is a negative result, that is, the sample to be tested does not contain Cryptosporidium nucleic acid.
[0121] Specific test results such as Figure 4 As shown in Table 4 , it can be seen that the detection values of other parasites were all less than 3 times of the negative control fluorescence value or had no typical amplification curve, and were all detected as negative.
[0122] Table 4 Detection results of Cryptosporidium and other parasite positive plasmids at the detection endpoint
[0123]
[0124] Example 4
[0125] Ten DNA samples that were positive for Cryptosporidium and ten DNA samples that were negative according to the national standard were tested with the RAP-CRISPR method of this application using the method and reagents of Example 3 to verify the detection effect of actual samples. The actual sample detection results are shown in Figure 5 As shown, samples 1-10 are all positive, and samples 11-20 are all negative.
[0126] Tiangen Environmental Microbial DNA Extraction Reagent (Cat. No. DP613) was used to extract nucleic acid from the above actual samples.
[0127] Comparative Example 1
[0128] In this comparative example, only the RPA reaction was used to detect the Cryptosporidium plasmid sample (20 copies / μl, 2 copies / μl).
[0129] Among them, RPA response:
[0130] Each reaction contained: RPA reaction beads, 2.5 μl of upstream and downstream primers cryRAAF4 (10 μM) and cryRAAR34 (10 μM), 5 μl of the sample to be tested, 20 μl of the dissolving agent, 17 μl of sterile RNase-free deionized water, and 3 μl of activation solution.
[0131] Incubate at 45 degrees for 20 minutes to obtain RPA product, and the detection result of RPA product is judged by specific bands of gel electrophoresis.
[0132] Test results such as Figure 6 As shown, A01 is the test result of 20 copies / μl, and a clear target area band can be seen. When the concentration drops to 2 copies / μl, the specific band is almost invisible. Figure 3 The test results shown in the figure show clear amplification curves for both 2 copies / μl and 1 copy / μl.
[0133] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0134] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims, and the description may be used to interpret the content of the claims.
Claims
1. Primer pairs for detecting Cryptosporidium, It is characterized in that The primer pair includes primers whose sequences are shown in SEQ ID NOs: 3-4.
2. crRNA for detecting Cryptosporidium, It is characterized in that The crRNA includes a crRNA whose sequence is shown in SEQ ID NO:
5.
3. Reagents for detecting Cryptosporidium, It is characterized in that The reaction reagents include RPA amplification reaction reagents and CRISPR detection reaction reagents; The RPA amplification reaction reagent includes the primer pair described in claim 1, and the CRISPR detection reaction reagent includes the crRNA described in claim 2.
4. The reaction reagent according to claim 3, It is characterized in that The RPA amplification reaction reagents also include one or more of RPA reaction microspheres and a dissolving agent for dissolving the microspheres.
5. The reaction reagent according to claim 3 or 4, It is characterized in that The CRISPR detection reaction reagent also includes one or more of a Cas12a enzyme, a CRISPR reaction buffer, and a ssDNA fluorescent reporter probe.
6. Kit for detecting Cryptosporidium, It is characterized in that The method comprises the primer pair according to claim 1, the crRNA according to claim 2, or the reaction reagent according to any one of claims 3 to 5.
7. Use of the primer pair according to claim 1, the crRNA according to claim 2, or the reaction reagent according to any one of claims 3 to 5 in preparing a kit for detecting Cryptosporidium.
8. Cryptosporidium detection method, It is characterized in that The steps include: Using DNA as a template, performing RPA isothermal amplification using the primer pair described in claim 1; Using the obtained RPA amplification product as a template, adding the CRISPR detection reaction reagent defined in claim 5 to carry out a CRISPR reaction, and detecting the fluorescent signal; as well as Determine whether the sample to be tested contains Cryptosporidium based on the test results.
9. The detection method according to claim 8, It is characterized in that RPA isothermal amplification meets one or more of the following conditions: (1) In the RPA isothermal amplification reaction system, the concentration of each primer is 0.3 μM to 1 μM; and (2) The reaction conditions of RPA isothermal amplification include a temperature of 40°C to 45°C and a time of 15 min to 30 min.
10. The detection method according to claim 8 or 9, It is characterized in that The CRISPR reaction meets one or more of the following conditions: (1) In the CRISPR reaction system, the concentrations of the crRNA, Cas12a enzyme protein and ssDNA fluorescent reporter probe are 5nM~10nM, 0.2μM~1μM and 0.2μM~1μM, respectively; and (2) CRISPR reaction conditions include temperature of 36°C~38°C and reaction time of 22min~30min.
